Chronic hepatitis D coinfection affects an estimated 12 million people globally, with higher prevalence in low-income and middle-income countries, especially the African and Western Pacific regions.
Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Argentine affiliate, Laboratorio LKM S.A., and its Mexican affiliate, ...
19h
Knight Therapeutics Announces Approval of Additional Indication for MINJUVI® (tafasitamab) in Brazil
Additionally, MONJUVI received accelerated approval in the United States in combination with lenalidomide for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma ...
Cboe Global Markets, Inc. (Cboe: CBOE), a leading global markets operator and pioneer in equity derivatives, announced it submitted ...
Taking Tanzania as an example, this paper systematically analyzes the current situation and challenges of primary school science education in Africa through questionnaires and interviews. The study ...
Firefighters at the site of an airstrike targeting the capital’s southern suburbs. Mourners at a funeral for members of Iraq's Hashed al-Shaabi, who were killed in an attack near the Syria border, on ...
The following students in grades 7-12 have qualified for the A and B Honor Roll for the third quarter of the 2025-26 school ...
COVID-19 immunization can protect and promote the health of Albertans and protect you from getting severely sick from COVID-19 infection. Additional information on the COVID-19 vaccine can be found ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results